Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-Plus: BEEP regimen followed by WBRT for breast cancer brain metastases
NCT02185352Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2014
- Primary completion
- Nov 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, brain metastases, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
breast cancerbrain metastases
Beyond the preview
Go deeper on NCT02185352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185352.